Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History.
International journal of chronic obstructive pulmonary disease/International journal of COPD（2023）
关键词
COPD,tiotropium bromide,olodaterol,fluticasone furoate,umeclidinium,vilanterol,exacerbation history,healthcare resource utilization,cost,clinical outcomes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要